Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC

Background and Aims: HBV shapes the T-cell immune responses in HBVrelated HCC. T cells can be recruited to the nidus, but limited T cells participate specifically in response to the HBV-related tumor microenvironment and HBV antigens. How epigenomic programs regulate T-cell compartments in virus-specific immune processes is unclear. Approach and Results: We developed Ti-ATAC-seq. 2 to map the T-cell receptor repertoire, epigenomic, and transcriptomic landscape of alpha ss T cells at both the bulk-cell and single-cell levels in 54 patients with HCC. We deeply investigated HBV-specific T cells and HBV-related T-cell subsets that specifically responded to HBV antigens and the HBV + tumor microenvironment, respectively, characterizing their T-cell receptor clonality and specificity and performing epigenomic profiling. A shared program comprising NFKB1/2-,Proto-Oncogene, NF-KB Sub unit, NFATC2-, and NR4A1-associated unique T-cell receptor-downstream core epigenomic and transcriptomic regulome commonly regulated the differentiation of HBV-specific regulatory T-cell (Treg) cells and CD8 + exhausted T cells; this program was also selectively enriched in the HBV-related Treg-CTLA4 and CD8-exhausted T cell-thymocyte selection associated high mobility subsets and drove greater clonal expansion in HBVrelated Treg-CTLA4 subset. Overall, 54% of the effector and memory HBVspecific T cells are governed by transcription factor motifs of activator protein 1, NFE2, and BACH1/2, which have been reported to be associated with prolonged patient relapse-free survival. Moreover, HBV-related tumor-infiltrating Tregs correlated with both increased viral titer and poor prognosis in patients. Conclusions: This study provides insight into the cellular and molecular basis of the epigenomic programs that regulate the differentiation and generation of HBVrelated T cells from viral infection and HBV + HCC unique immune exhaustion.

Automated summary

This study investigates the epigenomic programs that regulate the differentiation and generation of HBV-related T cells in response to viral infection and HBV + HCC unique immune exhaustion. The study also highlights the correlation between HBV-related tumor-infiltrating regulatory T cells and increased viral titer and poor prognosis in patients.